In Silico Molecular Docking and In Vitro Antidiabetic Studies of Dihydropyrimido[4,5-a]acridin-2-amines

Figure 1

I CDK inhibitor, II kinase inhibitor, III antitumor, IV antimalarial, V antimicrobial, and VI anti-inflammatory.